Category | Epidemic P. aeruginosa (n = 30) | Cohort with unique chronic P. aeruginosa infection | Entire CF cohort without epidemic P. aeruginosa | ||
---|---|---|---|---|---|
UNI (n = 67) | P Value | ENT (n = 112) | P Value | ||
Age | 32.81 (IQR 29.5–39.3) | 29.61 (IQR 24.9–41.9) | 0.13 | 29.5 (IQR 23.7–42.5) | 0.10 |
Gender (Female) | 17 (56.7Â %) | 40 (60Â %) | 0.48 | 60 (53.4Â %) | 0.84 |
Pancreatic Sufficient | 1 (3.3Â %) | 6 (9Â %) | 0.3 | 19 (17Â %) | 0.07 |
F508 del Homozygous | 18 (60Â %) | 37 (56Â %) | 0.44 | 56 (50Â %) | 0.42 |
≥1 F508del allele | 27 (90 %) | 57 (66 %) | 0.5 | 93 (83 %) | 0.56 |
Status post lung transplant | 12 (40Â %) | 9 (13.4Â %) | 0.005 | 12 (10.7Â %) | <0.001 |
Age at transplant | 29 (IQR 24.5–31.2) | 33.27 (IQR 23.4–35.7) | 0.53 | 33.9 (IQR 23.3–38.3) | 0.41 |
Chronic Infection Status | |||||
  P. aeruginosa | 30 (100 %) | 67 (100 %) | N/A | 67 (59.8 %) | <0.001 |
  S. aureus (MSSA) | 5 (20 %) | 29 (43.7) | 0.009 | 61 (54.5 %) | <0.001 |
 MSSA as sole pathogen | 0 | 0 | N/A | 21 (18.8 %) | 0.007 |
  S. aureus (MRSA) | 1 (3 %) | 3 (5 %) | 0.63 | 8 (7 %) | 0.68 |
  S. maltophilia | 0 | 0 | N/A | 2 (2 %) | 1 |
 Non-tuberculous mycobacteria | 0 | 6 (9 %) | 0.1 | 17 (15.1 %) | 0.02 |
  M. abscessus complexa | 0 | 2 (3 %) | 0.48 | 10 (9 %) | 0.12 |
  M. avium complex | 0 | 4 (6 %) | 0.22 | 7 (6 %) | 0.34 |
  A. xylosoxidans | 0 | 0 | N/A | 2 (2 %) | 1 |
  B. cepacia complex (Bcc)b | 1 (3 %) | 2 (3 %) | 0.67 | 4 (3.5 %) | 1 |
  Aspergillus fumigatus | 2 (6.6 %) | 2 (3 %) | 0.36 | 5 (4.5 %) | 0.64 |
 No chronic pathogens | 0 | 0 | N/A | 6 (5.3 %) | 0.34 |